SEC Company Response from PHYTOMEDICAL TECHNOLOGIES INC (CIK 0001002422) — Sep 14, 2005
PHYTOMEDICAL TECHNOLOGIES INC (CIK 0001002422)
Date: Sept. 14, 2005 · CIK: 0001002422 · Accession: 0001002422-05-000030
AI Filing Summary & Sentiment
File numbers found in text: 333-127650
Letter
Converted by FileMerlin
PHYTOMEDICAL TECHNOLOGIES, INC.
1628 West 1st Avenue
Suite 216
Vancouver, British Columbia, V6J 1G1
Telephone: (800) 611-3388
Facsimile: (604) 659-5029
September 14, 2005
Securities and Exchange Commission
100 F Street, NW
Washington, D.C. 20549-6010
Gregory S. Belliston (Mail Stop 6010)
RE:
Phytomedical Technologies, Inc. (the “Company”)
Registration Statement on Form SB-2
Filed August 18, 2005
File No. 333-127650
Gentlemen:
We enclose Amendment No. 1 to the above referenced registration statement on Form SB-2. On behalf of the Company, request is hereby made pursuant to Rule 461 of the Securities Act of 1933, as amended, that the effective date for the above-referenced Registration Statement be accelerated to 9:00 am Friday, September 16, 2005, or as soon as practicable thereafter.
In connection with the foregoing, we hereby acknowledge that:
- Should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filling;
- The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
- The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by Commission or any person under the federal securities laws of the United States.
Thank you for your courtesy, assistance and cooperation in this matter.
Very truly yours,
Phytomedical Technologies, Inc.
Show Raw Text
CORRESP 1 filename1.htm Converted by FileMerlin PHYTOMEDICAL TECHNOLOGIES, INC. 1628 West 1st Avenue Suite 216 Vancouver, British Columbia, V6J 1G1 Telephone: (800) 611-3388 Facsimile: (604) 659-5029 September 14, 2005 Securities and Exchange Commission 100 F Street, NW Washington, D.C. 20549-6010 Gregory S. Belliston (Mail Stop 6010) RE: Phytomedical Technologies, Inc. (the “Company”) Registration Statement on Form SB-2 Filed August 18, 2005 File No. 333-127650 Gentlemen: We enclose Amendment No. 1 to the above referenced registration statement on Form SB-2. On behalf of the Company, request is hereby made pursuant to Rule 461 of the Securities Act of 1933, as amended, that the effective date for the above-referenced Registration Statement be accelerated to 9:00 am Friday, September 16, 2005, or as soon as practicable thereafter. In connection with the foregoing, we hereby acknowledge that: - Should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filling; - The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and - The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by Commission or any person under the federal securities laws of the United States. Thank you for your courtesy, assistance and cooperation in this matter. Very truly yours, Phytomedical Technologies, Inc. By: /s/ Hamel S. Rayat Name: Harmel S. Rayat Title: President, Chief Executive Officer, Chief Financial Officer Principal Accounting Officer